News

Postmarketing clinical experience with ocriplasmin shows treatment success is higher when patients are chosen based on ideal criteria. No safety signals have emerged, but safety is being investigated more closely in ongoing trials.

Patients treated with aflibercept intravitreal injections for macular edema associated with branch retinal vein occlusion had a significantly greater decrease in central retinal thickness and significantly greater improvement in vision compared with laser at the end of the 52-week VIBRANT trial.

Studies that focus on switching treatments for exudative age-related macular degeneration may represent more real-life scenarios. However, future prospective studies with predetermined switching criteria and follow-up are needed.

An analysis of independent data published in AREDS Report 38 shows that the response of patients with moderate to advanced age-related macular degeneration (AMD) to treatment with zinc or the Age-Related Eye Disease Study (AREDS) formulation varied substantially based on genotype.

Sheldon Silver was, until recently, Speaker of the New York State Assembly. This post made him one of that state's two or three most powerful political figures. He was forced to resign his post when indicted for corruption.

Social media platforms are popular, multiplying, and potentially a way to reach patients with reliable information that could help build doctor-patient relationships and improve adherence to glaucoma medication.

Aflibercept is reportedly superior to ranibizumab and bevacizumab when treating some patients with diabetic macular edema (DME), according to a National Institutes of Health (NIH)-sponsored clinical trial.

Highly variable myopia shifts can occur in pseudophakic children. IOL exchange seems to be an acceptable option for treating the high myopia that can develop with lens implantation in children.However, the use of IOLs in growing eyes remains controversial, and outcomes are uncertain because of lack of data, according to Courtney Kraus, MD.

Vernon Benjamin Mountcastle, MD-recipient of the Lasker Award and the National Medal of Science-was the first person to understand how the cells in the higher regions of the brain are organized, earning him the nickname of "the Jacques Cousteau of the [cerebral] cortex." He was the first president of the Society for Neuroscience and editor of the Journal of Neurophysiology.